A new candidate vaccine against hepatitis E, developed collaboratively by GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research (WRAIR), was found to be 95.5% effective in a Phase Two trial, according to a study to be published in the New England Journal of Medicine.
A study published in the March 1 issue of the journal Sleep finds that people with obstructive sleep apnea (OSA) are at an increased risk of having cardiovascular disease.
A study published in the March 1 issue of the journal Sleep finds that sleep deprivation impairs the ability to integrate emotion and cognition to guide moral judgments.
A study published in the March 1 issue of the journal Sleep finds that, as opposed to treating insomnia, failure to treat it is much more costly.
AVANIR Pharmaceuticals (NASDAQ:AVNR) announced the Company has met with U.S. Food and Drug Administration (FDA) officials to address concerns expressed in the FDA’s October 30, 2006 approvable letter for Zenvia(TM) as a treatment for involuntary emotional expression disorder (IEED) and to present AVANIR’s proposed strategy to gain approval for Zenvia for this indication.
Delivering the keynote address on the theme ?Ecology and Health? at the inaugural function of the 13th Annual General Body Meeting and Continuing Medical Education Programme of the Sister Doctors Forum of India in New Delhi, the U nion Minister for Health & Family Welfare, Dr. Anbumani Ramadoss stated that involvement of the professionals to supplement the Government?s efforts in the health care delivery system is the need of the hour.
Pfizer Animal Health (PAH) announced the U.S. Food and Drug Administration (FDA) has approved Cerenia(TM) (maropitant citrate), the first medication to prevent and treat acute vomiting in dogs.
More than one in seven American adults have used nonprescription dietary supplements to try to lose weight, according to researchers at the U.S. Centers for Disease Control.
Even as the AIDS epidemic in Los Angeles County has shifted largely to Hispanics, primary-care practitioners serving this segment of the population often fail to offer either HIV testing or safer sex advice to their patients, according to a new UCLA AIDS Institute study
Researchers have found a way to activate Epstein-Barr viruses inside tumors as a way to identify patients whose infection can then be manipulated to destroy their tumors.